
Global Cord Blood Corporation CO
Annual report 2022
added 08-16-2022
Global Cord Blood Corporation Cash Conversion Cycle 2011-2026 | CO
Annual Cash Conversion Cycle Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 184 | 156 | 86.8 | 28.2 | 78.5 | 108 | 111 | 103 | 144 | 53.5 | 77.2 | 92.4 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 184 | 28.2 | 102 |
Quarterly Cash Conversion Cycle Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 41.2 | - | - | - | 64.1 | - | - | - | 11.8 | - | - | - | 29.9 | - | - | - | 47.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 64 | 142 | - | - | 35.4 | 158 | 188 | 80.5 | 42.3 | 44.2 | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 188 | 11.8 | 73 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Medpace Holdings
MEDP
|
50.4 | $ 460.74 | 0.83 % | $ 13.3 B | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
224 | $ 9.15 | 1.67 % | $ 610 M | ||
|
Biodesix
BDSX
|
41.7 | $ 15.54 | 5.79 % | $ 2.02 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.61 | -1.07 % | $ 427 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.44 | -0.4 % | $ 390 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
299 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Pacific Biosciences of California
PACB
|
185 | $ 1.39 | - | $ 417 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 159.19 | 0.75 % | $ 7.89 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 166.09 | -0.52 % | $ 28.6 B | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Personalis
PSNL
|
-11.5 | $ 7.78 | 2.23 % | $ 461 M | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
166 | $ 1.18 | -19.18 % | $ 6.43 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 264.46 | 1.94 % | $ 26.1 B | ||
|
Interpace Biosciences
IDXG
|
44.9 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
Illumina
ILMN
|
142 | $ 125.98 | 1.77 % | $ 20 B | ||
|
RadNet
RDNT
|
34.5 | $ 59.87 | -3.03 % | $ 4.5 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Precipio
PRPO
|
-3.19 | $ 26.6 | -1.23 % | $ 34.5 M | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 6.66 | 0.6 % | $ 278 M | ||
|
Sotera Health Company
SHC
|
33.5 | $ 13.84 | -0.32 % | $ 3.93 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 266.12 | 0.64 % | $ 22.1 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 31.34 | -1.2 % | $ 1.59 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 3.46 | -0.57 % | $ 1.86 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 7.86 | -2.96 % | $ 1.01 B | ||
|
Neuronetics
STIM
|
17.3 | $ 1.46 | -9.06 % | $ 96.3 M | ||
|
Natera
NTRA
|
81.5 | $ 194.52 | -2.78 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.84 | 1.59 % | $ 951 M | ||
|
OPKO Health
OPK
|
242 | $ 1.13 | -1.74 % | $ 784 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 25.35 | -1.55 % | $ 704 M | ||
|
DarioHealth Corp.
DRIO
|
115 | $ 7.76 | 3.47 % | $ 30.9 M | ||
|
DexCom
DXCM
|
134 | $ 66.6 | 1.0 % | $ 26 B | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | $ 104.91 | - | $ 19.8 B | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 47.49 | 6.72 % | $ 2.84 B |